Sapyen

Lab accuracy. Home comfort.

Melbourne, Australia · Founded 2021 · $10.1M raised

Headquarters
Melbourne
Employees
11–50
Founded
2021
Business Model
B2C
Website
sapyen.co
Total Funding
$10.1M
Last Round
$10.0M Series ANov 2021
Rounds
2

About

Sapyen is an Australian at-home male fertility diagnostics company founded in 2021, headquartered in Melbourne. The company offers a range of clinically accurate semen analysis tests that men can perform from home, with samples analyzed by accredited IVF and diagnostic laboratories. Sapyen's proprietary stabilization fluid keeps samples viable for up to three days during transport, enabling lab-grade accuracy without a clinic visit. Its test menu includes core semen analysis, DNA fragmentation testing, antisperm antibody testing, SpermEGT DNA methylation testing, post-vasectomy analysis, and sperm cryopreservation. Trusted by leading IVF networks including IVIRMA, Ivy Fertility, and Monash IVF, Sapyen has expanded to the United Kingdom, United States, Canada, and multiple European markets.

Summary

Sapyen is a Healthcare company based in Melbourne, Australia, founded in 2021. It has raised $10.1M in total across 2 rounds, most recently a $10.0M Series A round in Nov 2021. Investors include Antler.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundNov 2021
$141K

Sign up to see all 2 rounds

Series A through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sapyen on Indexed.vc
<a href="https://indexed.vc/companies/sapyen"><img src="https://indexed.vc/api/badge/company/sapyen" alt="Sapyen on Indexed.vc" width="260" height="76" /></a>